These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32341839)

  • 1. Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting?
    Cidad-Betegón MDP; Armadá-Maresca F; Amorena-Santesteban G; Coca-Robinot J; D'Anna-Mardero O; de la Rosa-Pérez I; Manzano-Muñoz B; García-Martínez J; Asencio-Durán M; Casado-Abad G
    J Drug Assess; 2020; 9(1):66-71. PubMed ID: 32341839
    [No Abstract]   [Full Text] [Related]  

  • 2. [ARCSTERILE: A COST-EFFECTIVE LUXURY].
    Fenoll MA
    Rev Enferm; 2015 May; 38(5):8-12. PubMed ID: 26540890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
    Larochelle MB; Smith J; Dacey MS
    Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients.
    Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M
    Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the release profile and pharmacokinetics of intact and fragmented dexamethasone intravitreal implants in rabbit eyes.
    Bhagat R; Zhang J; Farooq S; Li XY
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):854-8. PubMed ID: 25411827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
    Boyer DS; Yoon YH; Belfort R; Bandello F; Maturi RK; Augustin AJ; Li XY; Cui H; Hashad Y; Whitcup SM;
    Ophthalmology; 2014 Oct; 121(10):1904-14. PubMed ID: 24907062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
    Chang-Lin JE; Attar M; Acheampong AA; Robinson MR; Whitcup SM; Kuppermann BD; Welty D
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):80-6. PubMed ID: 20702826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
    Tsang AC; Virgili G; Abtahi M; Gottlieb CC
    Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Assessment of Dexamethasone Intravitreal Implant in DME: Findings of the Prospective, Multicenter REINFORCE Study.
    Singer MA; Dugel PU; Fine HF; Capone A; Maltman J
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jun; 49(6):425-435. PubMed ID: 29927470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and Visual Outcomes of Culture-Proven Endophthalmitis Following Dexamethasone Intravitreal Implant.
    Stem MS; Todorich B; Yonekawa Y; Capone A; Williams GA; Ruby AJ
    JAMA Ophthalmol; 2017 Apr; 135(4):379-382. PubMed ID: 28208166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release and velocity of micronized dexamethasone implants with an intravitreal drug delivery system: kinematic analysis with a high-speed camera.
    Meyer CH; Klein A; Alten F; Liu Z; Stanzel BV; Helb HM; Brinkmann CK
    Retina; 2012; 32(10):2133-40. PubMed ID: 23060033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study.
    Cho H; Choi KS; Lee JY; Lee D; Choi NK; Lee Y; Bae S
    BMJ Open; 2019 Sep; 9(9):e030930. PubMed ID: 31542758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Singer MA; Capone A; Dugel PU; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Apr; 15():33. PubMed ID: 25885285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Sustained-Release Dexamethasone Implant: Expanding Indications in Vitreoretinal Disease.
    Kapoor KG; Wagner MG; Wagner AL
    Semin Ophthalmol; 2015; 30(5-6):475-81. PubMed ID: 24654698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
    Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
    Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active removal of anterior segment-migrated dexamethasone implant (Ozurdex
    Depla JAM; Veckeneer M; Bleyen I
    GMS Ophthalmol Cases; 2022; 12():Doc08. PubMed ID: 35465301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.